Focal Segmental Glomerulosclerosis
Open accessThe DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Abstract
Focal segmental glomerulosclerosis (FSGS) is a leading cause of kidney disease worldwide. The presumed etiology of primary FSGS is a plasma factor with responsiveness to immunosuppressive therapy and a risk of recurrence after kidney transplant–important disease characteristics. In contrast, adaptive FSGS is associated with excessive nephron workload due to increased body size, reduced nephron capacity, or single glomerular hyperfiltration associated with certain diseases. Additional etiologies are now recognized as drivers of FSGS: high-penetrance genetic FSGS due to mutations in one of nearly 40 genes, virus-associated FSGS, and medication-associated FSGS. Emerging data support the identification of a sixth category: APOL1 risk allele–associated FSGS in individuals with sub-Saharan ancestry. The classification of a particular patient with FSGS relies on integration of findings from clinical history, laboratory testing, kidney biopsy, and in some patients, genetic testing. The kidney biopsy can be helpful, with clues provided by features on light microscopy ( e.g ., glomerular size, histologic variant of FSGS, microcystic tubular changes, and tubular hypertrophy), immunofluorescence ( e.g ., to rule out other primary glomerulopathies), and electron microscopy ( e.g. , extent of podocyte foot process effacement, podocyte microvillous transformation, and tubuloreticular inclusions). A complete assessment of renal histology is important for establishing the parenchymal setting of segmental glomerulosclerosis, distinguishing FSGS associated with one of many other glomerular diseases from the clinical-pathologic syndrome of FSGS. Genetic testing is beneficial in particular clinical settings. Identifying the etiology of FSGS guides selection of therapy and provides prognostic insight. Much progress has been made in our understanding of FSGS, but important outstanding issues remain, including the identity of the plasma factor believed to be responsible for primary FSGS, the value of routine implementation of genetic testing, and the identification of more effective and less toxic therapeutic interventions for FSGS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Focal segmental glomerulosclerosis (FSGS) is a fibrotic kidney disease characterized by glomerular lesions, particularly in podocytes — the formation of adhesions in the glomerular capillary tuft leads to capillary occlusion and nephron degeneration162.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [162]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028 · cited 1×
“More recently, efforts to identify genetic drivers of FSGS in at-risk populations have gained momentum, with the most recent addition including the APOL1 genetic variant as a major association with FSGS in individuals of sub-Saharan African descent with FSGS (23).”
BackgroundSelf-citationMann, J. F., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J., Wang, X., Maggioni, A., Budaj, A., Chaithiraphan, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61236-2 · Cited by 1,589
Combined angiotensin inhibition for the treatment of diabetic nephropathy
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O'Connor, T., Palevsky, P. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303154 · Cited by 1,169
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.9 · Cited by 966
KDIGO Clinical Practice Guideline for Glomerulonephritis
Eckardt, K., & Kasiske, B. L. (2012) · Cited by 893
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
Kopp, J. B., Nelson, G. W., Sampath, K., Johnson, R. C., Genovese, G., An, P., Friedman, D., Briggs, W., Dart, R., Korbet, S., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040388 · Cited by 855
Self-citationCirculating urokinase receptor as a cause of focal segmental glomerulosclerosis
Wei, C., El Hindi, S., Li, J., Fornoni, A., Goes, N., Sageshima, J., Maiguel, D., Karumanchi, S. A., Yap, H.-K., Saleem, M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2411 · Cited by 841
Cited by
Items 301–400 of 642
Heerspink, H. J. L., Fornoni, A., Inker, L. A., Noronha, I. D. L., Trimarchi, H., Wong, M. G., Smith, A. J., Shepherd, R. K., White, C. W., Fuller, D., et al. (2025) · Kidney International Reports · doi:10.1016/j.ekir.2025.09.044 · Cited by 4
Gene modification: Exploring the potential in treating kidney diseases
Ekperikpe, U. S., Zhao, S., & Daehn, I. S. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108104 · Cited by 5
Lin, L., Tian, E., Ren, J., Wu, Z., Deng, J., & Yang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.932739 · Cited by 4
Underlying Mechanisms and Treatment of Hypertension in Glomerular Diseases
Koubar, S. H., García‐Rivera, A., Mohamed, M. M. B., Hall, J. E., Hall, M. E., & Hassanein, M. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01287-9 · Cited by 4
A Review of Nephrotoxins and Their Mechanism of Nephrotoxicity
Sahu, V., Panjwani, D., & Mishra, V. (2024) · Current Functional Foods · doi:10.2174/0126668629274023240102075155 · Cited by 4
Abedi, M., Nili, F., Dehkhoda, F., Abdollahi, A., & Salarvand, S. (2024) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2024.152281 · Cited by 4
Hu, X., Lin, W., Luo, Z., Zhong, Y., Xiao, X., & Tang, R. (2024) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.70006 · Cited by 4
Jia, Y., Xiong, S., Chen, H., Liu, D., & Wu, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37866 · Cited by 4
Indications for genetic testing in adults with focal segmental glomerulosclerosis
Teran, M. P., Shabaka, A., Furlano, M. M., Tato, A., Carrillo, I. G., Gutiérrez, E., Torrá, R., & Juarez, G. M. F. (2025) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2025.02.001 · Cited by 4
Wang, L., Tang, Y., Buckley, A. F., & Spurney, R. F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319424 · Cited by 4
Gene Expression as a Guide to the Development of Novel Therapies in Primary Glomerular Diseases
Garantziotis, P., Doumas, S., Boletis, I. N., & Frangou, E. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112262 · Cited by 4
Floege, J., Gibson, K. L., Praga, M., Radhakrishnan, J., Reich, H. N., Schreuder, M. F., Wetzels, J. F. M., Tesař, V., Vivarelli, M., Biechele, S., et al. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.06.010 · Cited by 4
Srikantharajah, M., & McAdoo, S. P. (2023) · Medicine · doi:10.1016/j.mpmed.2023.01.003 · Cited by 4
Diagnostik und Therapie der Fokal-Segmentalen Glomerulosklerose – 2023
Gauckler, P., Zitt, E., Regele, H. M., Eller, K., Säemann, M. D., Lhotta, K., Neumann, I., Rudnicki, M., Odler, B., Kronbichler, A., et al. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02260-x · Cited by 4
El-Dehaibi, F., Zamora, R., Radder, J. E., Yin, J., Shah, A. M., Namas, R. A., Situ, M., Zhao, Y., Bain, W., Morris, A., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108333 · Cited by 4
Patel, N. K., Chen, K., Chen, S., & Liu, K. (2023) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13086 · Cited by 4
Sun, Y., Liu, S., Ding, W., Zhu, C., Jiang, G., & Li, H. (2025) · Kidney Diseases · doi:10.1159/000545240 · Cited by 4
Plant-Based Diet Mitigated the Risk of Chronic Kidney Disease in Overweight Individuals
Hou, Y., Tseng, K.-H., Tzeng, I., Tsai, W., Liu, H.-W., Liu, J., Kuo, K.-C., Lai, Y.-C., Lu, K., Lin, I.-H., et al. (2025) · Annals of Nutrition and Metabolism · doi:10.1159/000545953 · Cited by 4
Yonemura, T., Sarashina, A., Tachibana, Y., Retlich, S., & Soleymanlou, N. (2025) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2025.2510664 · Cited by 4
Vincristine Treatment Protects Against Podocyte Damage in Focal Segmental Glomerulosclerosis
Mason, W. J., Chandler, J. C., Gage, A. M., Pomeranz, G., Price, K. L., Antonelou, M., Henderson, S. R., Perin, L., Sacco, S. D., Salama, A. D., et al. (2025) · Kidney International Reports · doi:10.1016/j.ekir.2025.08.002 · Cited by 4
Miura, K., Kaneko, N., Hashimoto, T., Ishizuka, K., Shirai, Y., Hisano, M., Chikamoto, H., Akioka, Y., Kanda, S., Harita, Y., et al. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05604-3 · Cited by 4
Hu, S.-W., Wang, Y., Huang, J.-S., Yang, Y.-M., Wu, C., & Cheng, C. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120992 · Cited by 4
Horinouchi, T., Ueda, C., Kitakado, H., Yoshikawa, N., & Nozu, K. (2023) · Journal of Nephrology · doi:10.1007/s40620-023-01577-0 · Cited by 4
Pokharel, A., Anderson, J. D., Deebajah, M., Blatt, N. B., Reddy, G. H., Garlapaty, V. K., Li, W., Kanaan, H. D., & Zhang, P. L. (2023) · Ultrastructural Pathology · doi:10.1080/01913123.2023.2237565 · Cited by 4
Ran, L., Li, W., Zhang, H., Lin, J., Zhu, L., Long, H., Xiang, L., Chen, L., Li, Q., Hu, Y., et al. (2024) · Kidney & Blood Pressure Research · doi:10.1159/000538825 · Cited by 4
Luong, M. W., Wang, Y., Berasi, S. P., Buhlmann, J. E., Yang, H., & Gorovits, B. (2020) · The AAPS Journal · doi:10.1208/s12248-020-0431-x · Cited by 4
The Spectrum of Glomerular Diseases in Mashhad According to Kidney Biopsy Records.
Saberafsharian, M., Ravanshad, S., Hami, M., Sabbagh, M. G., Sanei, E., & Miri, M. (2020) · Iranian Journal of Kidney Diseases · doi:10.5254/ijkd.5114 · Cited by 4
Bezdíčka, M., Langer, J., Háček, J., & Zieg, J. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.583230 · Cited by 4
Shi, D., Zhang, Y., Liu, D., Li, X., & Tang, X. (2021) · Clinical Rheumatology · doi:10.1007/s10067-020-05574-7 · Cited by 4
Rovin, B. H., Caster, D. J., Cattran, D. C., Gibson, K. L., Hogan, J. J., Moeller, M. J., Roccatello, D., Cheung, M., Wheeler, D. C., Winkelmayer, W. C., et al. (2021) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2021-25-1-96-119 · Cited by 4
Miesen, L., Wetzels, R., Eymael, J., Mooren, F., Monge, V. V., van den Berge, B. T., van den Broek, M., van der Velden, T. J. A. M., van den Heuvel, L. P., Wetzels, J. F. M., et al. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112712 · Cited by 4
A Life-Changing Diagnosis of Focal Segmental Glomerulosclerosis in a Young Hispanic Male
Kaliounji, A., Farraj, K. L., Juta, R., & Kim, Z. (2021) · Cureus · doi:10.7759/cureus.20323 · Cited by 4
Watanabe, Y., Fujinaga, S., Sakuraya, K., Ikeda, H., & Nozu, K. (2022) · Clinical and Experimental Nephrology · doi:10.1007/s10157-021-02174-w · Cited by 4
Kidney Tubules — Scientific and Applied Value
Levitskaya, E. S., & Batiushin, M. M. (2022) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2022-12-6-405-421 · Cited by 4
Yin, D.-Y., Hou, G., Yang, X., Bi, L., Mei, X., Bai, M.-K., Zhou, L.-M., Shan, Z., & Huang, Y. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad027 · Cited by 4
Mbanefo, N. R., Igbokwe, O. O., Iloh, O., Chikani, U. N., Bisi-Onyemaechi, A., Muoneke, V., Okafor, H., Uwaezuoke, S. N., & Odetunde, O. I. (2023) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_855_22 · Cited by 4
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis
Groothof, D., Bakker, S. J. L., & Erler, N. S. (2024) · New England Journal of Medicine · doi:10.1056/nejmc2401126 · Cited by 4
Serum Factors in Primary Podocytopathies
Filippone, E. J., & Farber, J. L. (2025) · Antibodies · doi:10.3390/antib14040082 · Cited by 3
Takahashi, A., Kiyozawa, D., Miyauchi, T., Mirocha, J., Ren, Y. M. K., Doi, T., Choung, H. Y. G., Lin, M. Y., Hou, J., Masaki, T., et al. (2025) · Kidney Medicine · doi:10.1016/j.xkme.2025.101131 · Cited by 3
Yağın, F. H., İnceoğlu, F., Çolak, C., Alkhalifa, A. K., Alzakari, S. A., & Aghaei, M. (2025) · Pharmaceuticals · doi:10.3390/ph18111659 · Cited by 3
Özel, C., Reitmeier, K., Kieckhöfer, E., Abualia, K., Nguyen-Minh, D., Matin, M., Hagmann, H., Coward, R. J., Brähler, S., Antczak, P., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202502934r · Cited by 3
Morozov, S. L., & Dlin, V. V. (2021) · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) · doi:10.21508/1027-4065-2021-66-5-67-74 · Cited by 3
Focal Segmental Glomerulosclerosis Followed by Acute Hepatitis A Infection: Case Report
An, M.-W., Yoo, J., Kim, J. K., Moon, A., Kim, S. G., & Kim, Y. S. (2023) · Medicina · doi:10.3390/medicina59050819 · Cited by 3
Aldhouse, N. V. J., Kitchen, H., Al‐Zubeidi, T., Thursfield, M., Winnette, R., Tai, S. S., Zhu, L., Garnier, N., & Baker, C. L. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02651-6 · Cited by 3
Yamada, Y., Yokoyama, H., Kinoshita, R., Kitamoto, K., Kawaba, Y., Okada, S., Horie, T., Nagano, C., Nozu, K., & Namba, N. (2023) · CEN Case Reports · doi:10.1007/s13730-023-00830-6 · Cited by 3
Morguetti, M. J., Neves, P. D. M. D. M., Korkes, I., Padilha, W. S. C., Jorge, L., Watanabe, A., Watanabe, E. H., Malheiros, D. M. A. C., Noronha, I. D. L., Dib, S. A., et al. (2024) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2023-0204 · Cited by 3
Kösters, P., Cazorla‐Vázquez, S., Krüger, R., Daniel, C., Vonbrunn, E., Amann, K., & Engel, F. B. (2024) · Cells · doi:10.3390/cells13100874 · Cited by 3
Nephroprotective Effects of Curcumin in Murine Models of Focal and Segmental Glomerulosclerosis
Husain, S., Bayoumy, N. M. K., Noor, F., & Hagar, H. (2025) · Pharmacology · doi:10.1159/000543293 · Cited by 3
Clinical Decision-Making About Immunosuppressive Treatment in Focal Segmental Glomerulosclerosis
Blazius, B. A., Troost, J. P., Kopp, J. B., Parekh, R. S., Gillespie, B. W., Ayoub, I. M., Kallash, M., Gbadegesin, R., Canetta, P. A., Srivastava, T., et al. (2025) · Kidney Medicine · doi:10.1016/j.xkme.2025.100975 · Cited by 3
Self-citationvan den Berge, B. T., van den Broek, M., Giovanni, G. V. D., Dêbiec, H., Gloudemans, S., Leusink, Q. M., den Braanker, D., Wetzels, J. F. M., Ronco, P. M., Smeets, B., et al. (2025) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaf045 · Cited by 3
Develop and Validate a Risk Score in Predicting Renal Failure in Focal Segmental Glomerulosclerosis
Cai, Y., Liu, Y., Tong, J., Jin, Y., Liu, J., Xu, H., Ji, Y., Ma, J., Xiaoxia, P., Chen, N., et al. (2023) · Kidney Diseases · doi:10.1159/000529773 · Cited by 3
Pattern of Biopsy-Proven Renal Dysfunction in Pakistan: A Single Center Experience
Sultan, K. (2023) · Journal of Islamabad Medical & Dental College · doi:10.35787/jimdc.v12i2.782 · Cited by 3
Nephrotic syndrome due to focal segmental glomerulosclerosis complicating scleroderma: a case report
Dalivand, M. M., Hadjiabbasi, A., Ramezanzadeh, E., Habibzadeh, S. M., Goudarzi, K., Shahriarirad, R., & Zayeni, H. (2024) · Journal of Medical Case Reports · doi:10.1186/s13256-023-04273-6 · Cited by 3
Focal segmental glomerulosclerosis
Bloudíčková, S. R., & Thomasová, D. (2024) · Vnitřní lékařství · doi:10.36290/vnl.2024.030 · Cited by 3
Tang, C., Zhou, D., Tan, R., Zhong, X., Xiao, X., Qin, D., Liu, Y., Hu, J., & Liu, Y. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.10917 · Cited by 3
Pham, P. T., Pham, P. T., & Lew, S. Q. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00050-4 · Cited by 3
Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report
Choi, S. B., Kim, K. M., Park, M. H., & Kang, K. P. (2021) · Medicine · doi:10.1097/md.0000000000025857 · Cited by 3
Liang, R., Yang, X., Lin, S., Yi, W.-Q., Chen, X., Dong, X., Guo, L.-G., Li, Y., Zhao, Y.-R., & Xu, H. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-1962 · Cited by 3
Nongenetic Forms of Steroid-Resistant Nephrotic Syndrome
Kemper, M. J., Gibson, K. L., & Sinha, A. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-52719-8_93 · Cited by 3
Mutation in XPO5 causes adult-onset autosomal dominant familial focal segmental glomerulosclerosis
Hussain, H. M. J., Cai, Y., Weng, Q., Tong, J., Aftab, A., Jin, Y., Liu, J., Yu, S., Fang, Z., Du, W., et al. (2022) · Human Genomics · doi:10.1186/s40246-022-00430-y · Cited by 3
LDP alleviates TKI-induced proteinuria through reversing the expression of RelA in renal tissues
Fu, Z., Zhang, S., Gu, X., Guan, T., Wang, C., Zhang, J., Wang, Y., Guo, H., Wang, L., & Zhang, T. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1095344 · Cited by 3
Khatri, B., Baral, A., Maharjan, S., & Khatri, B. (2023) · Journal of Nepal Medical Association · doi:10.31729/jnma.8039 · Cited by 3
Precision nephrology: from molecular diagnostics to an individualized therapy
Mühlig, A. K., Oh, J. S., & Huber, T. B. (2023) · Kidney International · doi:10.1016/j.kint.2022.12.017 · Cited by 3
Gong, X., Huang, J., Zhang, Y., Wang, F., Wang, X., Meng, L., Cheng, X., Liu, G., Cui, Z., & Zhao, M. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2279642 · Cited by 3
The Protective Role of KANK1 in Podocyte Injury
Oda, K., Katayama, K., Zang, L., Toda, M., Tanoue, A., Saiki, R., Yasuma, T., D’Alessandro‐Gabazza, C. N., Shimada, Y., Mori, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115808 · Cited by 3
Nili, F., Saboori, F., Jahanzad, I., & Mehrazma, M. (2019) · Ultrastructural Pathology · doi:10.1080/01913123.2019.1584258 · Cited by 3
Inherited glomerular diseases in the gilded age of genomic advancements
Gulati, A., Dahl, N. K., & Tufró, A. (2019) · Pediatric Nephrology · doi:10.1007/s00467-019-04266-y · Cited by 3
Azhar, M., Alasadi, L., Kemnele, S., Reiser, I. W., & Spitalewitz, S. (2019) · American Journal of Case Reports · doi:10.12659/ajcr.917722 · Cited by 3
Nara, M., Kaga, H., Saito, M. M., Abe, F., Saito, A., Imaizumi, C., Komatsuda, A., Wakui, H., & Takahashi, N. (2021) · Internal Medicine · doi:10.2169/internalmedicine.6633-20 · Cited by 3
Focal Segmental Glomerulosclerosis
Mason, P. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-76419-7_21 · Cited by 3
The association between adult-onset Still’s disease and collapsing glomerulopathy: a case report
Orentas, M., Patel, N. P., Rodby, R. A., & Hassan, S. (2022) · Journal of Medical Case Reports · doi:10.1186/s13256-022-03606-1 · Cited by 3
Bielopolski, D., Streja, E., Steinmetz, T., Rozen‐Zvi, B., & Kalantar‐Zadeh, K. (2022) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000847 · Cited by 3
Mariani, L. H., Eddy, S. F., Alakwaa, F., McCown, P. J., Harder, J. L., Martini, S., Ademola, A. D., Boima, V., Reich, H. N., Eichinger, F. H., et al. (2021) · medRxiv · doi:10.1101/2021.09.09.21262925 · Cited by 3
Self-citationTrachtman, H., Inrig, J. K., & Komers, R. (2025) · Future Rare Diseases · doi:10.1080/23995270.2025.2461966 · Cited by 3
Analysis of glomerular deposition of IgM and C3 in patients with podocytopathies
Ferreira, V. A., da Silva, C. A., Neto, J. R. D. C., Rocha, L. P., Martins, A. L. M. D. S., dos Reis, M. A., & Machado, J. R. (2024) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2024.152292 · Cited by 2
Unmasking Focal Segmental Glomerulosclerosis in a Patient With Lupus Nephritis
Acob, T., Jumaah, O., Kakhktsyan, T., Hakobyan, K., & Prabhakaran, S. (2024) · Cureus · doi:10.7759/cureus.63008 · Cited by 2
Ge, Y., Liu, X., Shu, J., Jiang, X., & Wu, Y. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s498407 · Cited by 2
Miyazaki, R., Miyagi, K., Miyanaga, T., Shirai, Y., Miura, K., Hattori, M., Hara, S., Ito, K., Mizushima, I., & Iwata, Y. (2025) · Renal Replacement Therapy · doi:10.1186/s41100-025-00614-x · Cited by 2
Li, J., Yan, Y., Ouzaouit, A., Wang, J., Zhou, Y., Shi, H., Peprah, A. F., Jiang, T., & Lai, Y. (2025) · Next research. · doi:10.1016/j.nexres.2025.100345 · Cited by 2
Zhao, X., Wang, Z., Xia, Z., Chen, H., Zhu, Y., Wang, S., Bao, Y., Liu, Y., Wang, H., & Ao, Y. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02346-1 · Cited by 2
de la Cruz, C. O., Lagunas‐Rangel, F. A., Gómez‐García, A., & Chávez‐Valencia, V. (2025) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2025.501404 · Cited by 2
Mascarenhas‐Melo, F., Martins, B., Monteiro, I., Lohani, A., & Krambeck, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188760 · Cited by 2
Khan, A. H., Goorani, S., Atamanchuk, A., Jankiewicz, W. K., Yeboah, M. M., Barnett, S. D., Falck, J. R., Hwang, S. H., Barnych, B., Hammock, B. D., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178132 · Cited by 2
Miyasako, K., Maeoka, Y., Adachi, Y., Tamura, R., Ishiuchi, N., Nagano, C., Nozu, K., & Masaki, T. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04441-4 · Cited by 2
Clinical significance of genetic mutations in adult patients with focal segmental glomerulosclerosis
Min, M., Wang, Q., Zhu, L., Wang, J., & Zhang, J. (2025) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.25.082 · Cited by 2
Wang, T.-T., Lu, H., Shen, T., Chen, S.-L., He, Y.-B., Song, D.-M., Cui, X.-F., & Tong, M. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2620204 · Cited by 2
Hayashi, N., Akai, R., Kagaya, Y., Fujimoto, K., Iwawaki, T., Yokoyama, H., & Furuichi, K. (2026) · Scientific Reports · doi:10.1038/s41598-026-43612-7 · Cited by 2
Anti-CD38/Anti-CD20 Rescue Therapy for Posttransplant Recurrent FSGS
Léon, J., Ducrocq, E., Lafargue, M.-C., Bertrand, D., Maigret, L., Zaidan, M., Michon-Colin, A., Thervet, É., Dürrbach, A., Kamar, N., et al. (2026) · Kidney International Reports · doi:10.1016/j.ekir.2026.106668 · Cited by 2
Investigational drugs in development for focal segmental glomerulosclerosis
Trachtman, H. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1351544 · Cited by 2
Focal segmental glomerulosclerosis: challenges in definitions, pathogenesis and management
Feehally, J. (2017) · African Journal of Nephrology · doi:10.21804/20-1-2546 · Cited by 2
Case 1-2025: A 35-Year-Old Woman with Shortness of Breath and Edema in the Legs
Tangren, J. S., Jeyabalan, A., & Klepeis, V. E. (2025) · New England Journal of Medicine · doi:10.1056/nejmcpc2402498 · Cited by 2
Szklarzewicz, J., Floege, U., Gallego, D., Gibson, K. L., Kalantar‐Zadeh, K., Helm, K., Robinson, D., Schneider, B., Smith, P. A., Tullus, K., et al. (2025) · Quality of Life Research · doi:10.1007/s11136-025-03951-w · Cited by 2
Navarro, R., Hurtado-Aréstegui, A., Asato-Higa, C., & Úmeres, J. S. (2025) · Revista de la Sociedad Ecuatoriana de Nefrología Diálisis y Trasplante · doi:10.56867/111 · Cited by 2
Mystery Medications and Renal Failure
Toomey, D., Wiener, E., Greene, N. E., Weisman, A., Wittels, K. A., & Wilcox, S. R. (2020) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.03.031 · Cited by 2
Dudreuilh, C., Barbet, C., Gatault, P., Ferlicot, S., Lebranchu, Y., Rabot, N., Beaudreuil, S., Dürrbach, A., & Büchler, M. (2020) · Transplant International · doi:10.1111/tri.13796 · Cited by 2
Jalanko, H., & Kääriäinen, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-812534-2.00004-7 · Cited by 2
Ishigaki, S., Oe, Y., Omata, K., Ono, Y., Tezuka, Y., Morimoto, R., Watanabe, S., Nishioka, H., Satoh, F., Yoshida, M., et al. (2022) · CEN Case Reports · doi:10.1007/s13730-022-00739-6 · Cited by 2
Rheumatoid Arthritis With Focal Segmental Glomerulosclerosis: A Case Report and Literature Review
Albandak, M. E., Ayyad, M., Ajamia, S. A., Quntar, A., Al-Karaja, L., Alsaid, H., & Alamlih, L. I. (2023) · Cureus · doi:10.7759/cureus.37161 · Cited by 2
Survival outcomes of HIV-positive adults on peritoneal dialysis at Helen Joseph renal unit
Thomas, K. L., & Davies, M. (2023) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v24i1.1471 · Cited by 2
Satish, S., Paul, E., Kelur, K., & Shetty, M. S. (2023) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_593_21 · Cited by 2
Metadata
- Authors
- Rosenberg, A. Z., & Kopp, J. B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Rosenberg, Avi Z.
- Kopp, Jeffrey B.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2017-02-27
- Volume
- 12
- Issue
- 3
- Pages
- 502-517
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- PMC
- PMC5338705
- OpenAlex
- W2593771998
- Cited by
- 562
- References
- 145
- Citations by year
- 2026: 43 · 2025: 71 · 2024: 86 · 2023: 79 · 2022: 79 · 2021: 62 · 2020: 65 · 2019: 46 · 2018: 22 · 2017: 9
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Keywords
- focal segmental glomerulosclerosis, APOL1 risk alleles, renal biopsy, podocyte ultrastructure, genetic testing
- MeSH terms
- Apolipoprotein L1, Angiotensin-Converting Enzyme Inhibitors, Drug Therapy, Combination, Glomerulosclerosis, Focal Segmental, Glucocorticoids, Humans, Immunosuppressive Agents, HIV Infections, Angiotensin Receptor Antagonists, Calcineurin Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.